130 related articles for article (PubMed ID: 27199221)
1. Tumor radiosensitization by gene therapy against endoglin.
Stimac M; Kamensek U; Cemazar M; Kranjc S; Coer A; Sersa G
Cancer Gene Ther; 2016 Jul; 23(7):214-20. PubMed ID: 27199221
[TBL] [Abstract][Full Text] [Related]
2. Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects.
Stimac M; Dolinsek T; Lampreht U; Cemazar M; Sersa G
PLoS One; 2015; 10(4):e0124913. PubMed ID: 25909447
[TBL] [Abstract][Full Text] [Related]
3. Endoglin silencing has significant antitumor effect on murine mammary adenocarcinoma mediated by vascular targeted effect.
Dolinsek T; Markelc B; Bosnjak M; Blagus T; Prosen L; Kranjc S; Stimac M; Lampreht U; Sersa G; Cemazar M
Curr Gene Ther; 2015; 15(3):228-44. PubMed ID: 25619888
[TBL] [Abstract][Full Text] [Related]
4. Tumor Radiosensitization by Gene Electrotransfer-Mediated Double Targeting of Tumor Vasculature.
Savarin M; Znidar K; Sersa G; Komel T; Cemazar M; Kamensek U
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769077
[TBL] [Abstract][Full Text] [Related]
5. Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response.
Savarin M; Kamensek U; Cemazar M; Heller R; Sersa G
Radiol Oncol; 2017 Mar; 51(1):30-39. PubMed ID: 28265230
[TBL] [Abstract][Full Text] [Related]
6. Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth.
Dolinsek T; Markelc B; Sersa G; Coer A; Stimac M; Lavrencak J; Brozic A; Kranjc S; Cemazar M
PLoS One; 2013; 8(3):e58723. PubMed ID: 23593103
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
8. Intravital Monitoring of Vasculature After Targeted Gene Therapy Alone or Combined With Tumor Irradiation.
Savarin M; Prevc A; Rzek M; Bosnjak M; Vojvodic I; Cemazar M; Jarm T; Sersa G
Technol Cancer Res Treat; 2018 Jan; 17():1533033818784208. PubMed ID: 29969947
[TBL] [Abstract][Full Text] [Related]
9. Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects.
Dolinsek T; Sersa G; Prosen L; Bosnjak M; Stimac M; Razborsek U; Cemazar M
Cancers (Basel); 2015 Dec; 8(1):. PubMed ID: 26712792
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma.
Sedlar A; Kranjc S; Dolinsek T; Cemazar M; Coer A; Sersa G
BMC Cancer; 2013 Jan; 13():38. PubMed ID: 23360213
[TBL] [Abstract][Full Text] [Related]
12. Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.
Shibata MA; Shibata E; Morimoto J; Harada-Shiba M
Anticancer Res; 2013 Oct; 33(10):4237-47. PubMed ID: 24122987
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.
Jarosz M; Jazowiecka-Rakus J; Cichoń T; Głowala-Kosińska M; Smolarczyk R; Smagur A; Malina S; Sochanik A; Szala S
Gene Ther; 2013 Mar; 20(3):262-73. PubMed ID: 22495576
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
15. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Novel Plasmid for Simultaneous Gene Electrotransfer-Mediated Silencing of CD105 and CD146 in Combination with Irradiation.
Savarin M; Kamensek U; Znidar K; Todorovic V; Sersa G; Cemazar M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802812
[TBL] [Abstract][Full Text] [Related]
17. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
18. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.
Zou L; Song X; Yi T; Li S; Deng H; Chen X; Li Z; Bai Y; Zhong Q; Wei Y; Zhao X
Cancer Gene Ther; 2013 Apr; 20(4):242-50. PubMed ID: 23492823
[TBL] [Abstract][Full Text] [Related]
19. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
Zhang M; Yan L; Kim JA
Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
[TBL] [Abstract][Full Text] [Related]
20. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
Jiao JG; Zhang YD; Li YN
Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
